NPI: 1245233014 · MERRILLVILLE, IN 46410 · 207W00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,475 | $58K |
| 2019 | 11,638 | $234K |
| 2020 | 7,855 | $212K |
| 2021 | 9,265 | $309K |
| 2022 | 9,966 | $381K |
| 2023 | 11,474 | $543K |
| 2024 | 8,737 | $357K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | 12,494 | 11,321 | $693K | |
| 67028 | 11,764 | 9,713 | $474K | |
| 92134 | 17,215 | 15,454 | $298K | |
| J9035 | Bevacizumab injection | 3,222 | 2,737 | $180K |
| J0178 | Aflibercept injection | 187 | 165 | $162K |
| J2777 | Inj, faricimab-svoa, 0.1mg | 115 | 95 | $111K |
| 92202 | 6,538 | 6,033 | $49K | |
| 99204 | 736 | 680 | $49K | |
| 92235 | 764 | 709 | $32K | |
| 92014 | 2,038 | 1,793 | $16K | |
| 92226 | 2,353 | 1,777 | $16K | |
| 92250 | 473 | 429 | $7K | |
| 99213 | 92 | 88 | $5K | |
| J3590 | Unclassified biologics | 1,434 | 1,103 | $2K |
| 92225 | 170 | 135 | $217.06 | |
| G9903 | Pt scrn tbco id as non user | 3,165 | 2,860 | $0.00 |
| G8397 | Dil macula/fundus exam/w doc | 418 | 362 | $0.00 |
| 67228 | 15 | 14 | $0.00 | |
| G8427 | Docrev cur meds by elig clin | 4,809 | 4,315 | $0.00 |
| 2022F | 928 | 839 | $0.00 | |
| 5010F | 419 | 364 | $0.00 | |
| G2102 | Dil retinal eye exam | 61 | 59 | $0.00 |